Emerging biologics in severe asthma

類似資料

• Interleukin-5 inhibitors for severe asthma: Rationale and future outlook.
  著者:: Shrimanker, R, 等
  出版事項: (2017)
• Evidence for the efficacy and safety of anti- interleukin-5 treatment in the management of refractory eosinophilic asthma
  著者:: Xue, L, 等
  出版事項: (2015)
• Management and mechanisms of severe eosinophilic asthma
  著者:: Shrimanker, R
  出版事項: (2020)
• Exacerbations of severe asthma in patients treated with mepolizumab
  著者:: Shrimanker, R, 等
  出版事項: (2018)
• Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
  著者:: Howell, I, 等
  出版事項: (2024)